<DOC>
	<DOCNO>NCT00604253</DOCNO>
	<brief_summary>This trial conduct Japan . The aim trial investigate efficacy insulin detemir blood glucose control type 2 diabetes add current OHA treatment .</brief_summary>
	<brief_title>Efficacy Safety Insulin Detemir Type 2 Diabetes Inadequately Controlled OHA Therapy Alone</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Isophane insulin , beef</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Detemir</mesh_term>
	<mesh_term>Isophane Insulin , Human</mesh_term>
	<mesh_term>Insulin , Isophane</mesh_term>
	<criteria>Duration type 2 diabetes mellitus least one year Insulin naive patient OHA treatment least 12 week HbA1C 7.510.0 % Body Mass Index ( BMI ) 30.0 kg/m2 Impaired renal function Impaired hepatic function Pregnant , breastfeeding ( within year delivery ) , intention become pregnant use adequate contraceptive method</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>